Literature DB >> 19906411

Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.

Rebecca Brooks1, Nora Kizer, Loan Nguyen, Atthapon Jaishuen, Karolyn Wanat, Elizabeth Nugent, Perry Grigsby, Jenifer E Allsworth, Janet S Rader.   

Abstract

OBJECTIVE: Heritable polymorphisms modulate metastatic efficiency in Cancer Single nucleotide polymorphisms (SNPs) in MMP9 (rs17576) and SIPA1 (rs746429, rs931127) have been associated with nodal metastases in multiple cancers. We investigated the association of these SNPs with nodal metastases in early-stage cervical cancer.
METHODS: Consecutive patients with stage IB cervical cancer who underwent a pelvic lymph node (LN) dissection were included. Cases (>1 positive LN, n=101) were compared with controls (negative LN pathology, n=273). Genotyping was performed on genomic DNA in the 3 SNPs using a TaqMan assay and correlated with clinical variables.
RESULTS: The G allele at SIPA1 rs931127 was associated with an increased risk of nodal disease (OR 1.9, P=0.03) and approached significance at SIPA 1 rs746429 (OR 2.2, P=0.09) and MMP9 rs17576 (OR 1.5, 0.08). In patients with stage Ib1 lesions (n=304), the G allele at both SIPA1 SNPs was associated with LN metastases (rs746429 OR 10.1, P=0.01; rs931127 OR 2.4, P=0.01). In patients with no lymph vascular space invasion, SIPA1 SNPs were again associated with LN metastases, and all patients with nodal disease had at least one G allele at SIPA1 rs746429.
CONCLUSIONS: In this case-control study, SNPs in SIPA1 varied statistically in cervical cancer patients with and without nodal metastases and in MMP9 after controlling for stage and lymphvascular space invasion. Further work is needed to characterize inherited polymorphisms that provide a permissive background for the metastatic cascade.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906411      PMCID: PMC2822070          DOI: 10.1016/j.ygyno.2009.09.037

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  36 in total

1.  Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.

Authors:  B Zhang; A Henney; P Eriksson; A Hamsten; H Watkins; S Ye
Journal:  Hum Genet       Date:  1999-11       Impact factor: 4.132

2.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

3.  Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.

Authors:  Elena I Deryugina; Andries Zijlstra; Juneth J Partridge; Tatyana A Kupriyanova; Mark A Madsen; Thales Papagiannakopoulos; James P Quigley
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

4.  Genetic flip-flop without an accompanying change in linkage disequilibrium.

Authors:  Dmitri V Zaykin; Kyoko Shibata
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

5.  Combination of microarray profiling and protein-protein interaction databases delineates the minimal discriminators as a metastasis network for esophageal squamous cell carcinoma.

Authors:  Fen-Hwa Wong; Chi-Ying F Huang; Li-Jen Su; Yu-Chung Wu; Yong-Shiang Lin; Jiun-Yi Hsia; Hsin-Ting Tsai; Sheng-An Lee; Chi-Hung Lin; Cheng-Hwai Tzeng; Po-Min Chen; Yann-Jan Chen; Shu-Ching Liang; Jin-Mei Lai; Chueh-Chuan Yen
Journal:  Int J Oncol       Date:  2009-01       Impact factor: 5.650

6.  The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB.

Authors:  T Inoue; K Morita
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860

7.  Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.

Authors:  Hedvig Hricak; Constantine Gatsonis; Dennis S Chi; Marco A Amendola; Kathy Brandt; Lawrence H Schwartz; Susan Koelliker; Evan S Siegelman; Jeffrey J Brown; Robert B McGhee; Revathy Iyer; Kenneth M Vitellas; Bradley Snyder; Harry J Long; James V Fiorica; Donald G Mitchell
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

8.  Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.

Authors:  Chunyuan Yu; Kaifeng Pan; Deyin Xing; Gang Liang; Wen Tan; Lian Zhang; Dongxin Lin
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

9.  Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice.

Authors:  Toru Nakamura; Toshio Kuwai; Jang-Seong Kim; Dominic Fan; Sun-Jin Kim; Isaiah J Fidler
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

10.  Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma.

Authors:  Javier Cotignola; Boris Reva; Nandita Mitra; Nicole Ishill; Shaokun Chuai; Ami Patel; Shivang Shah; Gretchen Vanderbeek; Daniel Coit; Klaus Busam; Allan Halpern; Alan Houghton; Chris Sander; Marianne Berwick; Irene Orlow
Journal:  BMC Med Genet       Date:  2007-03-08       Impact factor: 2.103

View more
  9 in total

Review 1.  Genetic insights into the morass of metastatic heterogeneity.

Authors:  Kent W Hunter; Ruhul Amin; Sarah Deasy; Ngoc-Han Ha; Lalage Wakefield
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

2.  Sipa1 deficiency-induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm.

Authors:  Pingnan Xiao; Monika Dolinska; Lakshmi Sandhow; Makoto Kondo; Anne-Sofie Johansson; Thibault Bouderlique; Ying Zhao; Xidan Li; Marios Dimitriou; George Z Rassidakis; Eva Hellström-Lindberg; Nagahiro Minato; Julian Walfridsson; David T Scadden; Mikael Sigvardsson; Hong Qian
Journal:  Blood Adv       Date:  2018-03-13

3.  The SIPA1 -313A>G polymorphism is associated with prognosis in inoperable non-small cell lung cancer.

Authors:  Agnieszka Gdowicz-Kłosok; Monika Giglok; Anna Drosik; Rafał Suwiński; Dorota Butkiewicz
Journal:  Tumour Biol       Date:  2014-10-29

Review 4.  The role of individual inheritance in tumor progression and metastasis.

Authors:  Kent Hunter
Journal:  J Mol Med (Berl)       Date:  2015-06-10       Impact factor: 4.599

5.  Matrix metalloproteinase-9 genetic variation and primary angle closure glaucoma in a Caucasian population.

Authors:  Mona S Awadalla; Kathryn P Burdon; Abraham Kuot; Alex W Hewitt; Jamie E Craig
Journal:  Mol Vis       Date:  2011-05-27       Impact factor: 2.367

6.  A scan for genes associated with cancer mortality and longevity in pedigree dog breeds.

Authors:  Aoife Doherty; Inês Lopes; Christopher T Ford; Gianni Monaco; Patrick Guest; João Pedro de Magalhães
Journal:  Mamm Genome       Date:  2020-07-13       Impact factor: 2.957

7.  Suppression of SIPA-1 expression may reduce bladder cancer invasion and metastasis via the downregulation of E-cadherin and ZO-1.

Authors:  Ping Zhang; Xinghuan Wang
Journal:  Exp Ther Med       Date:  2015-11-24       Impact factor: 2.751

8.  Label-Free Quantitative Proteomic Analysis of Differentially Expressed Membrane Proteins of Pulmonary Alveolar Macrophages Infected with Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus and Its Attenuated Strain.

Authors:  Zehui Qu; Fei Gao; Liwei Li; Yujiao Zhang; Yifeng Jiang; Lingxue Yu; Yanjun Zhou; Hao Zheng; Wu Tong; Guoxin Li; Guangzhi Tong
Journal:  Proteomics       Date:  2017-11-24       Impact factor: 3.984

9.  Association between matrix metalloproteinase-9 gene polymorphism and breast cancer in Brazilian women.

Authors:  Victor Alves de Oliveira; Diego Cipriano Chagas; Jefferson Rodrigues Amorim; Renato de Oliveira Pereira; Thais Alves Nogueira; Victória Maria Luz Borges; Larysse Maira Campos-Verde; Luana Mota Martins; Gilmara Peres Rodrigues; Elmo de Jesus Nery Júnior; Fabiane Araújo Sampaio; Pedro Vitor Lopes-Costa; João Marcelo de Castro E Sousa; Vladmir Costa Silva; Felipe Cavalcanti Carneiro da Silva; Benedito Borges da Silva
Journal:  Clinics (Sao Paulo)       Date:  2020-10-26       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.